is saxenda a glp 1 drug (Liraglutide) Liraglutide: Uses, Side Effects, Dosages,
Description
F., & STEP 1 Study Group (2021)
Orskov C, Poulsen SS, Mller M, Holst JJ
The study concluded that in patients with obesity-related heart failure and T2DM with preserved ejection fraction, semaglutide treatment resulted in significantly greater reductions in heart failure-related symptoms and physical limitations, as well as more pronounced weight loss at one year compared to placebo
The paper by Dejgaard and colleagues reviewed here represents a subanalysis of two studies published in 2016
doi: 10.1038/s41573-021-00337-8 52 NahraRWangTGaddeKMOscarssonJStumvollMJermutusLet al
